Indication

Diabetic peripheral neuropathy

Diabetic peripheral neuropathy is a chronic microvascular complication of diabetes mellitus characterized by progressive, length-dependent nerve injury to the peripheral nervous system. Read more about Diabetic peripheral neuropathy

97 drugs 64 manufacturers

Advertisement

Drugs that treat it

Common Diabetic peripheral neuropathy therapies.

Showing 37–45 of 97 drugs

PREGABALIN

ANTICONVULSANTS·POSTHERPETIC NEURALGIA·+4
ALEMBIC PHARMAC

PREGABALIN

ANTICONVULSANTS·POSTHERPETIC NEURALGIA·+4
SCIEGEN PHARMAC

PREGABALIN

ANTICONVULSANTS·POSTHERPETIC NEURALGIA·+4
NOVADOZ PHARMAC

PREGABALIN

ANTICONVULSANTS·POSTHERPETIC NEURALGIA·+4
ASCEND LABORATO

PREGABALIN

ANTICONVULSANTS·POSTHERPETIC NEURALGIA·+4
GREENSTONE LLC.
Filter & compare in the drug finder →Opens the drug finder with Diabetic peripheral neuropathy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Diabetic peripheral neuropathy.

Diabetic peripheral neuropathy is a chronic microvascular complication of diabetes mellitus characterized by progressive, length-dependent nerve injury to the peripheral nervous system.

Driven primarily by sustained hyperglycemia, oxidative stress, and microcirculatory impairment, the condition commonly manifests as a distal symmetric polyneuropathy that begins in the toes and lower extremities before advancing proximally in a characteristic stocking-and-glove distribution.

Clinically, affected individuals may experience positive sensory symptoms—such as burning pain, paresthesias, hyperalgesia, and allodynia—or negative symptoms, including numbness and sensory loss that increase the risk of ulceration and limb amputation.

Personalize your experience

Follow Diabetic peripheral neuropathy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it